| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.34 | 1e-05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 7e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |